Immunohistochemical and molecular pattern of p53 in epithelial ovarian cancers negative for germline BRCA1/2 variants
Pathology - Research and Practice · 2024
DOI: 10.1016/j.prp.2024.155183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Susanna Ronchi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Pathology, Ospedale di Circolo, ASST SetteLaghi, Research Center for Familial and Hereditary Tumors, Department of Medicine and Surgery, Univ…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Fallopian Tube Neoplasms, Cystadenocarcinoma, Serous. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regione Campania, Università degli Studi dell'Insubria, AstraZeneca.
Abstract (Originalsprache)
Epithelial ovarian cancers (EOC) associated with germline or somatic BRCA pathogenetic variants have a significantly higher rate of TP53aberrations. The majority of TP53 mutations are detectable by immunohistochemistry and several studies demonstrated that an abnormal p53 pattern characterized high-grade EOCs. An abnormal p53 immunohistochemical staining in fallopian tube (serous tubal intraepithelial carcinoma (STIC) and "p53 signature" is considered as a precancerous lesion of high-grade EOCs and it is often found in fallopian tube tissues of BRCA germline mutated patients suggesting that STIC is an early lesion and the TP53 mutation is an early driver event of BRCA mutated high-grade EOCs. No relevant data are present in literature about the involvement of p53 abnormal pattern in EOC carcinogenesis of patients negative for germline BRCA variants. We describe TP53 mutation results in relationship to the immunohistochemical pattern of p53 expression in a series of EOCs negative for BRCA1 and BRCA2 germline mutations. In addition, we also investigated STIC presence and "p53 signature" in fallopian tube sampling of these EOCs. Our results demonstrate that TP53 alterations are frequent and early events in sporadic EOCs including also low-grade carcinomas. Also in this series, STIC is associated with an abnormal p53 pattern in fallopian tubes of high-grade EOCs. In summary, TP53 aberrations are the most frequent and early molecular events in EOC carcinogenesis independently from BRCA mutation status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Pathology, Ospedale di Circolo, ASST SetteLaghi, Research Center for Familial and Hereditary Tumors, Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy. Electronic address: Susanna.r…
- Unit of Pathology, Ospedale di Circolo, ASST SetteLaghi, Research Center for Familial and Hereditary Tumors, Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy. Electronic address: sofia.fac…
- Unit of Pathology, Ospedale di Circolo, ASST SetteLaghi, Research Center for Familial and Hereditary Tumors, Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy. Electronic address: Eleonora.…
- Unit of Pathology, Ospedale di Circolo, ASST SetteLaghi, Research Center for Familial and Hereditary Tumors, Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy. Electronic address: laura.lib…
- Unit of Pathology, Ospedale di Circolo, ASST SetteLaghi, Research Center for Familial and Hereditary Tumors, Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy. Electronic address: ileana.ca…
- Department of Obstetric and Gynecology, ASST Settelaghi, University of Insubria, 21100 Varese, Italy. Electronic address: Francesca.zefiro@asst-settelaghi.it.
Förderung
- Regione Campania
- Università degli Studi dell'Insubria
- AstraZeneca
- Fondazione Umberto Veronesi
Zitieren
APA
Ronchi, S., Facchi, S., Di Lauro, E., Libera, L., Carnevali, I. W., Zefiro, F., Alexandrova, E., Rizzo, F., Sessa, F., & Tibiletti, M. G. (2024). Immunohistochemical and molecular pattern of p53 in epithelial ovarian cancers negative for germline BRCA1/2 variants. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155183
Vancouver
Ronchi S, Facchi S, Di Lauro E, Libera L, Carnevali IW, Zefiro F, et al. Immunohistochemical and molecular pattern of p53 in epithelial ovarian cancers negative for germline BRCA1/2 variants. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155183
BibTeX
@article{Ronchi2024,
author = {Ronchi, Susanna and Facchi, Sofia and Di Lauro, Eleonora and Libera, Laura and Carnevali, Ileana Wanda and Zefiro, Francesca and Alexandrova, Elena and Rizzo, Francesca and Sessa, Fausto and Tibiletti, Maria Grazia},
title = {Immunohistochemical and molecular pattern of p53 in epithelial ovarian cancers negative for germline BRCA1/2 variants},
journal = {Pathology - Research and Practice},
year = {2024},
doi = {10.1016/j.prp.2024.155183}
}
EUVIMED